Submit Manuscript  

Article Details


Quinoxalinone as a Privileged Platform in Drug Development

[ Vol. 18 , Issue. 5 ]

Author(s):

Leilei Shi, Wei Hu, Jifeng Wu, Huaiyu Zhou, Hua Zhou and Xun Li*   Pages 392 - 413 ( 22 )

Abstract:


Among the family of nitrogen-containing heterocycles, quinoxalinone (or quinoxalin-2-one) core, characterized by pyrazin-2(1H)-one fused to benzene ring at two adjacent carbon atoms, has been frequently found in a variety of pharmacologically active compounds with biological or pharmaceutical applications. It was gratifying that a larger part of these bioactive quinoxalinone-based derivatives has entered various clinical trials, which in turn hastens the synthetic versatility and also initiates various derivatization of quinoxalinone scaffold. In this review, we highlighted the newly emerged quinoxalinone- based derivatives or analogues, with the emphasis of their biological applications and structure-activity analysis covering literatures in recent years.

Keywords:

Binding mode, biological activities, derivates, quinoxaline, quinoxalinone skeleton, SAR analysis.

Affiliation:

Key Laboratory of Chemistry and Chemical Biology (Ministry of Education), Department of Pharmaceutical Science, College of Pharmacy, Shandong University, Jinan, State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Ji'nan, Institute of Criminal Science and Technology, Ji'nan Public Security Bureau, Department of Pathogen Biology, School of Basic Medical Sciences, Shandong University, Jinan, Department of Chemistry, Texas A&M University, College Station, TX 77843, Key Laboratory of Chemistry and Chemical Biology (Ministry of Education), Department of Pharmaceutical Science, College of Pharmacy, Shandong University, Jinan

Graphical Abstract:



Read Full-Text article